In a 2-year carcinogenicity study in Sprague Dawley rats, subcutaneous doses of 0.0025, 0.01, 0.025 and 0.1 mg/kg/day were administered (below quantification, 0.4-, 1-, and 6-fold the exposure at the MRHD)
HR 1.19, 95% CI 0.91.58), but not for the other DPP-4 inhibitors as in the TECOS study for sitagliptin (HR 1.00, 95% CI 0.831.20) or the CARMELINA study for linagliptin (HR 0.90, 95% CI 0.741.08) (57, 62, 64, 65, 68)
No single type of exercise was clearly superior, although mixed exercise programmes and resistance training appeared slightly more effective than aerobic exercise alone
While semaglutide works by reducing appetite, some individuals may experience gastrointestinal discomfort, including nausea, which can result in decreased food intake
Allow a refrigerated or frozen vial to reach room temperature before opening, since introducing solvent into a cold vial encourages condensation